Craft

AngioDynamics

Stock Price

$6.9

2024-10-29

Market Capitalization

$282 M

2024-10-29

Revenue

$292.5 M

FY, 2025

AngioDynamics Summary

Company Summary

Overview
AngioDynamics is a company that provides medical solutions. It operates through two divisions: Med Tech and Med Device. The Med Tech segment includes systems, cannulas, aspiration devices, thrombolytic catheters, etc. The Med Device segment offers angiographic catheters and guidewires, micropuncture kits, ports, and other products.
Type
Public
Status
Active
Founded
1988
HQ
Latham, NY, US | view all locations
Website
https://www.angiodynamics.com/
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

Key People

  • Jim Clemmer

    Jim Clemmer, President, Chief Executive Officer and Director

    • Steve Trowbridge

      Steve Trowbridge, Executive Vice President, Chief Financial Officer

    • Benjamin Davis

      Benjamin Davis, Senior Vice President, Business Development, Strategy and R&D

    • Warren Nighan

      Warren Nighan, Senior Vice President, Quality, Regulatory Affairs

      Operating MetricsView all

      Manufacturing Facilities

      2

      FY, 2023

      Manufacturing Facilities, sq. ft.

      156K
      33.6%

      FY, 2023

      Research and Development Centers

      2

      FY, 2023

      LocationsView all

      8 locations detected

      • Latham, NY HQ

        United States

        14 Plaza Dr

      • Glens Falls, NY

        United States

        8 Glens Falls Tech Park

      • Marlborough, MA

        United States

        26 Forest St

      • Queensbury, NY

        United States

        603 Queensbury Ave

      • Oakville, ON

        Canada

        2275 Upper Middle Rd E #101

      • Hong Kong, Hong Kong Island

        Hong Kong

        Suite 6, 6/F Luk Kwok Centre 72 Gloucester Road

      and 2 others

      AngioDynamics Financials

      Summary Financials

      Revenue (Q3, 2026)
      $78.4M
      Gross profit (Q3, 2026)
      $41.5M
      Net income (Q3, 2026)
      ($8.1M)
      Cash (Q3, 2026)
      $37.8M
      EBIT (Q3, 2026)
      ($13.0M)

      Footer menu